2-((4-((3-ethylphenyl)amino)-6-(2-methoxyethoxy)quinazolin-7-yl)oxy)ethanol

IMPURITIES

Product Details

CAT No.# CS-O-34202
Category Impurities
CAS NA
Molecular Weight 383.44
Molecular Formula C21H25N3O4
Purity: >98
Synonyms: Erlotinib Impurity-VII
COA / MSDS:    View COA    MSDS    Enquire
The balance used are calibrated with weights traceable to National Standards NIST for accuracy
Related Results for '2-((4-((3-ethylphenyl)amino)-6-(2-methoxyethoxy)quinazolin-7-yl)oxy)ethanol'

- API Standards of Erlotinib
- Stable Isotopes of Erlotinib
- Metabolites of Erlotinib
- Impurities of Erlotinib
- Glucuronides of Erlotinib
- Intermediates of Erlotinib

PEOPLE ALSO SEARCHED FOR: 1. 2-((4-((3-ethynylphenyl)amino)-6-(2-methoxyethoxy)quinazolin-7-yl)oxy)ethyl acetate
2. (E)-6-Iodo-3-[2-(pyridin-2-yl)ethenyl]-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
3. Ethyl 2-(3,4-Dihydro-7-methoxy-1(2H)-naphthalenylidene)acetate
4. N-(2-(7-methoxy-3,4-dihydronaphthalen-1(2H)-ylidene)ethyl)acetamide
5. Trans-2-methyl-5-amino-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]-pyrrole fumarate
6. 2-(3,4-Dihydro-7-methoxy-1(2H)-naphthalenylidene)acetic acid
7. (S)-N6,N6-dipropyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine
8. Lamotrigine EP Impurity B
9. 3-(4-Chlorobutanoyl)-5-cyanoindole
10. 6-iodo-3-(2-(pyridin-2-yl)ethyl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole
11. 7-Methoxy-1-naphthaleneacetamide
12. (E)-Ethyl 2-cyano-5-methylhex-2-enoate
13. 2-chloro-1-(4-octylphenyl)ethanone
14. Axitinib Des Iodo analog
15. 7-methyl sulphinyl heptyl isothiocyanate
16. CHLOROFURANTOIN
17. Piperacillin Impurity 10
18. Praziquantel Impurity F
19. 1-Isocyanato-2-[(4-isocyanatophenyl)methyl]benzene
20. Osimertinib Impurity occurring at RRT of about 1.3


SMILES:
CCC1=CC=CC(NC2=NC=NC3=CC(OCCO)=C(OCCOC)C=C23)=C1



This page contains information about 2-((4-((3-ethylphenyl)amino)-6-(2-methoxyethoxy)quinazolin-7-yl)oxy)ethanol Cas NA and its Impurities.
"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."